ATRO vs HON: Which Is the Better Buy in 2026?

Same yardstick, side by side (as of November 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

Reading it: ATRO is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. ATRO and HON share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined ATRO and HON exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

Astronics Corporation has been in East Aurora, New York since 1968, and it sells components rather than aircraft. The Aerospace segment, about 93 percent of revenue, supplies electrical power generation and distribution systems, in-seat and cabin power (the EmPower line is on more than a million seats across 260-plus airlines and holds a dominant share of narrowbody in-seat power), lighting and safety systems, seat motion, avionics and aircraft structures. The smaller Test Systems segment builds automated test equipment for defense and mass transit, and its anchor program is the U.S. Army TS-4549/T radio test set, an IDIQ contract initially funded at roughly $215 million that entered full-rate production with a ~$44.7 million order in June 2026. Customers are the airframers, the seat and interior integrators, the in-flight entertainment vendors and government programs, so revenue tracks other people's production schedules more than end-consumer demand.

Full ATRO guide

Honeywell, which now operates as Honeywell Technologies (Nasdaq: HON), describes itself as a global, pure-play automation company serving the building, industrial and process sectors through services, solutions and products, run on its Accelerator operating system and its Forge intelligence layer. It has more than 50,000 employees and decades of operating data from a global installed base. Its Building Automation business sells controls, sensors, fire and security systems for commercial buildings. Industrial Automation covers process control, sensing, warehouse automation and the productivity (barcode scanning) business, and the process-technology franchise licenses refining and petrochemical technology and supplies the equipment and services around it, such as its planned role at the Dangote refinery project in Kenya. Honeywell makes money from a mix of equipment sales, long-cycle projects, recurring service and growing software offerings.

Full HON guide

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

• ATRO drivers: Aircraft build rates and the retrofit cycle; Margin expansion, not just volume.
• HON drivers: Pure-play automation focus; Software and physical AI on the installed base.

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: The valuation is the first risk: at roughly 34 times trailing earnings, 20 times forward and about 2.8 times TTM revenue, the stock is priced for the margin trajectory to continue, and a single quarter of build-rate softness or program timing slippage tends to hit small-cap suppliers hard. For HON, as a standalone automation company, Honeywell is more exposed to construction activity, manufacturing capex and energy-sector spending than when aerospace aftermarket revenue cushioned results.

Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick ATRO if you believe its drivers more; HON if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the ATRO and HON guides.

ATRO. The re-rating has partly reversed: earnings growth cut the trailing multiple from about 75 to about 34, and the share price is well off its high, so the forward multiple of about 20 now sits closer to aerospace component peers. Analysts expect 2026 EPS of about $2.70 and 2027 of about $3.04 on revenue of roughly $1.03 billion and $1.13 billion. The third-quarter report, expected around November 10, 2026, is the next check on whether margins hold.

HON. Honeywell's headline numbers are hard to read because the June 2026 aerospace spin-off and a large Q2 gain sit inside the trailing figures, which is why the trailing P/E shows near 8x. On forward estimates the stock trades around 22x 2027 EPS of about $9.82, a multiple in line with quality automation peers. The Q3 report on October 22 (consensus EPS about $2.16 on revenue of about $5.0 billion) will give the first clean standalone quarter.

Headline figures (approximate, October 2026): ATRO shows revenue (ttm) ~$942M, q2 2026 sales ~$260M, up ~27% year over year, margins (ttm) Gross ~32%, operating ~15%, net ~8%, net income (ttm) ~$79M, EPS ~$1.83; HON shows revenue (ttm, includes aerospace until june) ~$38.1 billion, q2 2026 revenue (continuing operations) ~$5.2 billion, 2026 revenue (analyst consensus) ~$20.2 billion, operating margin ~20%.

ATRO and HON are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined ATRO and HON exposure against your real portfolio. It is not an investment adviser.